{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:01:04Z","timestamp":1794258064661,"version":"4.9.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R307-2018-3326"],"award-info":[{"award-number":["R307-2018-3326"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R311-A18254"],"award-info":[{"award-number":["R311-A18254"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65048-9","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T16:28:45Z","timestamp":1763396925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["\u03b2-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-6898","authenticated-orcid":false,"given":"Klaire Yixin","family":"Fj\u00e6stad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4948-6799","authenticated-orcid":false,"given":"Astrid Zedlitz","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin James","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milou","family":"Schattefor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Kolvig","family":"Czajkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Thorseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1030-182X","authenticated-orcid":false,"given":"Majken","family":"Siersb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5388-6827","authenticated-orcid":false,"given":"Annina","family":"Kurzay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Perez-Penco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rahbech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6869-7337","authenticated-orcid":false,"given":"Sara Fresnillo","family":"Sal\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Henning","family":"Engelholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-6037","authenticated-orcid":false,"given":"Inge Marie","family":"Svane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2914-9605","authenticated-orcid":false,"given":"Mads Hald","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-9363","authenticated-orcid":false,"given":"Niels","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6735-8483","authenticated-orcid":false,"given":"Lars","family":"Gr\u00f8ntved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per thor","family":"Straten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3183-6201","authenticated-orcid":false,"given":"Daniel Hargb\u00f8l","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"65048_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"Hanahan, D. & Monje, M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell 41, 573\u2013580 (2023).","journal-title":"Cancer Cell"},{"key":"65048_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1158\/2159-8290.CD-23-1495","volume":"14","author":"M Amit","year":"2024","unstructured":"Amit, M. et al. Next directions in the neuroscience of cancers arising outside the CNS. Cancer Discov. 14, 669\u2013673 (2024).","journal-title":"Cancer Discov."},{"key":"65048_CR3","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","volume":"186","author":"F Winkler","year":"2023","unstructured":"Winkler, F. et al. Cancer neuroscience: State of the field, emerging directions. Cell 186, 1689\u20131707 (2023).","journal-title":"Cell"},{"key":"65048_CR4","doi-asserted-by":"publisher","first-page":"250ra115","DOI":"10.1126\/scitranslmed.3009569","volume":"6","author":"CM Zhao","year":"2014","unstructured":"Zhao, C. M. et al. Denervation suppresses gastric tumorigenesis. Sci. Transl. Med. 6, 250ra115 (2014).","journal-title":"Sci. Transl. Med."},{"key":"65048_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon, C. et al. Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361 (2013).","journal-title":"Science"},{"key":"65048_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","volume":"578","author":"M Amit","year":"2020","unstructured":"Amit, M. et al. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature 578, 449\u2013454 (2020).","journal-title":"Nature"},{"key":"65048_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/CMR.0000000000000943","volume":"34","author":"B Switzer","year":"2024","unstructured":"Switzer, B., Puzanov, I., Gandhi, S. & Repasky, E. A. Targeting beta-adrenergic receptor pathways in melanoma: how stress modulates oncogenic immunity. Melanoma Res. 34, 89\u201395 (2024).","journal-title":"Melanoma Res."},{"key":"65048_CR8","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour, H. et al. \u03b22 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J. Clin. Invest. 129, 5537\u20135552 (2019).","journal-title":"J. Clin. Invest."},{"key":"65048_CR9","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1158\/2326-6066.CIR-18-0833","volume":"7","author":"C Daher","year":"2019","unstructured":"Daher, C. et al. Blockade of \u03b2-adrenergic receptors improves CD8+ T-cell priming and cancer vaccine efficacy. Cancer Immunol. Res. 7, 1849\u20131863 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"65048_CR10","first-page":"171","volume":"13","author":"A Scanzano","year":"2015","unstructured":"Scanzano, A. & Cosentino, M. Adrenergic regulation of innate immunity: a review. Front. Parmacol. 13, 171 (2015).","journal-title":"Front. Parmacol."},{"key":"65048_CR11","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00262-023-03445-z","volume":"72","author":"S Thapa","year":"2023","unstructured":"Thapa, S. & Cao, X. Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases. Cancer Immunol. Immunother. 72, 2549\u20132556 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"65048_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","volume":"622","author":"AM Globig","year":"2023","unstructured":"Globig, A. M. et al. The \u03b21-adrenergic receptor links sympathetic nerves to T cell exhaustion. Nature 622, 383\u2013392 (2023).","journal-title":"Nature"},{"key":"65048_CR13","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","volume":"77","author":"MJ Bucsek","year":"2017","unstructured":"Bucsek, M. J. et al. \u03b2-Adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in cd8+ t cells and undermines checkpoint inhibitor therapy. Cancer Res. 77, 5639\u20135651 (2017).","journal-title":"Cancer Res."},{"key":"65048_CR14","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41388-021-02170-0","volume":"41","author":"KY Fj\u00e6stad","year":"2022","unstructured":"Fj\u00e6stad, K. Y. et al. Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. Oncogene 41, 1364\u20131375 (2022).","journal-title":"Oncogene"},{"key":"65048_CR15","doi-asserted-by":"publisher","first-page":"109883","DOI":"10.1016\/j.celrep.2021.109883","volume":"37","author":"H Mohammadpour","year":"2021","unstructured":"Mohammadpour, H., MacDonald, C. R., McCarthy, P. L., Abrams, S. I. & Repasky, E. A. \u03b22-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME. Cell Rep. 37, 109883 (2021).","journal-title":"Cell Rep."},{"key":"65048_CR16","doi-asserted-by":"publisher","first-page":"175718","DOI":"10.1016\/j.ejphar.2023.175718","volume":"949","author":"Y Lin","year":"2023","unstructured":"Lin, Y. et al. Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer. Eur. J. Pharmacol. 949, 175718 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"65048_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.18632\/oncoscience.413","volume":"5","author":"CN Amaya","year":"2018","unstructured":"Amaya, C. N. et al. Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma. Oncoscience 5, 109\u2013119 (2018).","journal-title":"Oncoscience"},{"key":"65048_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101289","volume":"23","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells. iScience 23, 101289 (2020).","journal-title":"iScience"},{"key":"65048_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker, P. H. et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12, 939\u2013944 (2006).","journal-title":"Nat. Med."},{"key":"65048_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7426","volume":"10","author":"JWL Eng","year":"2015","unstructured":"Eng, J. W. L. et al. Housing temperature-induced stress drives therapeutic resistance in murine tumour models through \u03b22-adrenergic receptor activation. Nat. Commun. 10, 6426 (2015).","journal-title":"Nat. Commun."},{"key":"65048_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17384-1","volume":"11","author":"C Nuevo-Tapioles","year":"2020","unstructured":"Nuevo-Tapioles, C. et al. Coordinate \u03b2-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth. Nat. Commun. 11, 3606 (2020).","journal-title":"Nat. Commun."},{"key":"65048_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","volume":"23","author":"L Cassetta","year":"2023","unstructured":"Cassetta, L. & Pollard, J. W. A timeline of tumour-associated macrophage biology. Nat. Rev. Cancer 23, 238\u2013257 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"65048_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev-pathmechdis-012418-013058","volume":"16","author":"S Ugel","year":"2021","unstructured":"Ugel, S., Canegrave, S., De Sanctis, F. & Bronte, V. Monocytes in the tumor microenvironment. Annu. Rev. Pathol. 16, 93\u2013122 (2021).","journal-title":"Annu. Rev. Pathol."},{"key":"65048_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","volume":"21","author":"SA Lasser","year":"2024","unstructured":"Lasser, S. A., Ozbay Kurt, F. G., Arkhypov, I., Utikal, J. & Umansky, V. Myeloid-derived suppressor cells in cancer and cancer therapy. Nat. Rev. Clin. Oncol. 21, 147\u2013164 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"65048_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet, M. J., Michielin, O. & Migliorini, D. Clinical relevance of tumour-associated macrophages. Nat. Rev. Clin. Oncol. 19, 402\u2013421 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"65048_CR26","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.4049\/jimmunol.1201391","volume":"190","author":"J Herv\u00e9","year":"2013","unstructured":"Herv\u00e9, J. et al. \u03b22-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells. J. Immunol. 190, 3163\u20133171 (2013).","journal-title":"J. Immunol."},{"key":"65048_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4049\/jimmunol.1501206","volume":"196","author":"MC Takenaka","year":"2016","unstructured":"Takenaka, M. C. et al. Norepinephrine Controls Effector T Cell Differentiation through \u03b22-Adrenergic Receptor-Mediated Inhibition of NF-\u03baB and AP-1 in Dendritic Cells. J. Immunol. 196, 637\u2013644 (2016).","journal-title":"J. Immunol."},{"key":"65048_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15676-0","volume":"11","author":"M Chen","year":"2020","unstructured":"Chen, M. et al. Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation. Nat. Commun. 11, 1821 (2020).","journal-title":"Nat. Commun."},{"key":"65048_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00262-018-2243-8","volume":"68","author":"G Qiao","year":"2019","unstructured":"Qiao, G. et al. \u03b2-Adrenergic signaling blocks murine CD8 + T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol. Immunother. 68, 11\u201322 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"65048_CR30","doi-asserted-by":"crossref","unstructured":"Hinkle, L. et al. The sympathetic nervous system modulates cancer vaccine activity through monocyte-derived cells.J. Immunol. 207, 3131\u20133140 (2021).","DOI":"10.4049\/jimmunol.2100719"},{"key":"65048_CR31","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1073\/pnas.0808851106","volume":"106","author":"KM Grebe","year":"2009","unstructured":"Grebe, K. M. et al. Sympathetic nervous system control of anti-influenza CD8+ T cell responses. Proc. Natl Acad. Sci. 106, 5300\u20135305 (2009).","journal-title":"Proc. Natl Acad. Sci."},{"key":"65048_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451299","volume":"54","author":"C Watzl","year":"2024","unstructured":"Watzl, C. et al. Chronic stimulation desensitizes \u03b2 2 adrenergic receptor responses in Natural Killer cells. Eur. J. Immunol. 54, e2451299 (2024).","journal-title":"Eur. J. Immunol."},{"key":"65048_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbi.2016.05.017","volume":"58","author":"L Sorski","year":"2016","unstructured":"Sorski, L. et al. Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through \u03b2-adrenoceptors blockade and COX2 inhibition. Brain Behav. Immun. 58, 91\u201398 (2016).","journal-title":"Brain Behav. Immun."},{"key":"65048_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13030394","volume":"13","author":"AWP Jensen","year":"2021","unstructured":"Jensen, A. W. P., Carnaz Sim\u00f5es, A. M., Thor Straten, P. & Holmen Olofsson, G. Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe? Cancers 13, 1\u201316 (2021).","journal-title":"Cancers"},{"key":"65048_CR35","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","volume":"574","author":"E Alspach","year":"2019","unstructured":"Alspach, E. et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature 574, 696\u2013701 (2019).","journal-title":"Nature"},{"key":"65048_CR36","doi-asserted-by":"publisher","first-page":"867189","DOI":"10.3389\/fimmu.2022.867189","volume":"13","author":"M Cenerenti","year":"2022","unstructured":"Cenerenti, M., Saillard, M., Romero, P. & Jandus, C. The Era of Cytotoxic CD4 T Cells. Front. Immunol. 13, 867189 (2022).","journal-title":"Front. Immunol."},{"key":"65048_CR37","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","volume":"54","author":"DY Oh","year":"2021","unstructured":"Oh, D. Y. & Fong, L. Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox. Immunity 54, 2701\u20132711 (2021).","journal-title":"Immunity"},{"key":"65048_CR38","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","volume":"618","author":"B Kruse","year":"2023","unstructured":"Kruse, B. et al. CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours. Nature 618, 1033\u20131040 (2023).","journal-title":"Nature"},{"key":"65048_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi9517","volume":"9","author":"EG Bawden","year":"2024","unstructured":"Bawden, E. G. et al. CD4+ T cell immunity against cutaneous melanoma encompasses multifaceted MHC II\u2013dependent responses. Sci. Immunol. 9, eadi9517 (2024).","journal-title":"Sci. Immunol."},{"key":"65048_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe3348","volume":"7","author":"A Cachot","year":"2021","unstructured":"Cachot, A. et al. Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer. Sci. Adv. 7, eabe3348 (2021).","journal-title":"Sci. Adv."},{"key":"65048_CR41","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","volume":"181","author":"DY Oh","year":"2021","unstructured":"Oh, D. Y. et al. Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer. Cell 181, 1612\u20131625.e13 (2021).","journal-title":"Cell"},{"key":"65048_CR42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20091918","volume":"207","author":"SA Quezada","year":"2010","unstructured":"Quezada, S. A. et al. Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J. Exp. Med. 207, 637\u2013650 (2010).","journal-title":"J. Exp. Med."},{"key":"65048_CR43","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.phrs.2019.104587","volume":"151","author":"C Fumagalli","year":"2020","unstructured":"Fumagalli, C., Maurizi, N., Marchionni, N. & Fornasari, D. -blockers: Their new life from hypertension to cancer and migraine. Pharmacol. Res. 151, 104587 (2020).","journal-title":"Pharmacol. Res."},{"key":"65048_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ebiom.2016.02.026","volume":"6","author":"E Pasquier","year":"2016","unstructured":"Pasquier, E. et al. Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: a bench to bedside study. EBioMedicine 6, 87\u201395 (2016).","journal-title":"EBioMedicine"},{"key":"65048_CR45","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cpt.1894","volume":"108","author":"P Liao","year":"2020","unstructured":"Liao, P. et al. Propranolol suppresses the growth of colorectal cancer through simultaneously activating autologous CD8+ T Cells and Inhibiting Tumor AKT\/MAPK Pathway. Clin. Pharmacol. Ther. 108, 606\u2013615 (2020).","journal-title":"Clin. Pharmacol. Ther."},{"key":"65048_CR46","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.18632\/oncotarget.14119","volume":"8","author":"A Montoya","year":"2017","unstructured":"Montoya, A. et al. Use of non-selective \u03b2-blockers is associated with decreased tumor proliferative indices in early stage breast cancer. Oncotarget 8, 6446\u20136460 (2017).","journal-title":"Oncotarget"},{"key":"65048_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf1147","volume":"15","author":"A Chang","year":"2023","unstructured":"Chang, A. et al. Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer. Sci. Transl. Med. 15, eadf1147 (2023).","journal-title":"Sci. Transl. Med."},{"key":"65048_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/CEJ.0000000000000192","volume":"25","author":"S Zhong","year":"2016","unstructured":"Zhong, S. et al. -Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies. Eur. J. Cancer Prev. 25, 440\u2013448 (2016).","journal-title":"Eur. J. Cancer Prev."},{"key":"65048_CR49","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","volume":"29","author":"TI Barron","year":"2011","unstructured":"Barron, T. I., Connolly, R. M., Sharp, L., Bennett, K. & Visvanathan, K. Beta blockers and breast cancer mortality: a population- based study. J. Clin. Oncol. 29, 2635\u20132644 (2011).","journal-title":"J. Clin. Oncol."},{"key":"65048_CR50","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","volume":"29","author":"A Melhem-Bertrandt","year":"2011","unstructured":"Melhem-Bertrandt, A. et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J. Clin. Oncol. 29, 2645\u20132652 (2011).","journal-title":"J. Clin. Oncol."},{"key":"65048_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejca.2022.01.017","volume":"165","author":"OJ Kennedy","year":"2022","unstructured":"Kennedy, O. J. et al. Prognostic and predictive value of \u03b2-blockers in the EORTC 1325\/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma. Eur. J. Cancer 165, 97\u2013112 (2022).","journal-title":"Eur. J. Cancer"},{"key":"65048_CR52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/1078-0432.CCR-20-2381","volume":"27","author":"S Gandhi","year":"2021","unstructured":"Gandhi, S. et al. Phase I clinical trial of combination propranolol and pembrolizumab in locally advanced and metastatic melanoma: safety, tolerability, and preliminary evidence of antitumor activity. Clin. Cancer Res. 27, 87\u201395 (2021).","journal-title":"Clin. Cancer Res."},{"key":"65048_CR53","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10549-021-06210-x","volume":"188","author":"MB Hopson","year":"2021","unstructured":"Hopson, M. B. et al. Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer. Breast Cancer Res. Treat. 188, 427\u2013432 (2021).","journal-title":"Breast Cancer Res. Treat."},{"key":"65048_CR54","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1002\/cncr.32950","volume":"126","author":"R Haldar","year":"2020","unstructured":"Haldar, R. et al. Perioperative COX2 and \u03b2-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial. Cancer 126, 3991\u20134001 (2020).","journal-title":"Cancer"},{"key":"65048_CR55","doi-asserted-by":"publisher","first-page":"113974","DOI":"10.1016\/j.ejca.2024.113974","volume":"202","author":"A Embaby","year":"2024","unstructured":"Embaby, A. et al. Propranolol monotherapy in angiosarcoma \u2013 A window-of-opportunity study (PropAngio). Eur. J. Cancer 202, 113974 (2024).","journal-title":"Eur. J. Cancer"},{"key":"65048_CR56","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","volume":"113","author":"L Chiossone","year":"2009","unstructured":"Chiossone, L. et al. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113, 5488\u20135496 (2009).","journal-title":"Blood"},{"key":"65048_CR57","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.4049\/jimmunol.1900778","volume":"204","author":"AM Johnson","year":"2020","unstructured":"Johnson, A. M. et al. Cancer cell-intrinsic expression of mhc class ii regulates the immune microenvironment and response to anti-pd-1 therapy in lung adenocarcinoma. J. Immunol. 204, 2295\u20132307 (2020).","journal-title":"J. Immunol."},{"key":"65048_CR58","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-024-08076-7","volume":"636","author":"MA Cardenas","year":"2024","unstructured":"Cardenas, M. A. et al. Differentiation fate of a stem-like CD4 T cell controls immunity to cancer. Nature 636, 224\u2013232 (2024).","journal-title":"Nature"},{"key":"65048_CR59","doi-asserted-by":"publisher","first-page":"101509","DOI":"10.1016\/j.smim.2021.101509","volume":"54","author":"A Sehgal","year":"2021","unstructured":"Sehgal, A., Irvine, K. M. & Hume, D. A. Functions of macrophage colony-stimulating factor (CSF1) in development, homeostasis, and tissue repair. Semin. Immunol. 54, 101509 (2021).","journal-title":"Semin. Immunol."},{"key":"65048_CR60","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"65048_CR61","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.1158\/0008-5472.CAN-06-0854","volume":"66","author":"A Anichini","year":"2006","unstructured":"Anichini, A. et al. Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients. Cancer Res. 66, 6405\u20136411 (2006).","journal-title":"Cancer Res."},{"key":"65048_CR62","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-22-3853","volume":"29","author":"A Draghi","year":"2023","unstructured":"Draghi, A. et al. Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma. Clin. Cancer Res. 29, 3937\u20133947 (2023).","journal-title":"Clin. Cancer Res."},{"key":"65048_CR63","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","volume":"19","author":"DE Sanford","year":"2013","unstructured":"Sanford, D. E. et al. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2\/CCR2 axis. Clin. Cancer Res. 19, 3404\u20133415 (2013).","journal-title":"Clin. Cancer Res."},{"key":"65048_CR64","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222\u2013225 (2011).","journal-title":"Nature"},{"key":"65048_CR65","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/cancers17101638","volume":"17","author":"MR Patysheva","year":"2025","unstructured":"Patysheva, M. R., Fedorenko, A. A., Khozyainova, A. A., Denisov, E. V. & Gerashchenko, T. S. Immune Evasion in Cancer Metastasis: An Unappreciated Role of Monocytes. Cancers 17, 1638 (2025).","journal-title":"Cancers"},{"key":"65048_CR66","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.18632\/oncotarget.7376","volume":"7","author":"SY Lim","year":"2016","unstructured":"Lim, S. Y., Yuzhalin, A. E., Gordon-Weeks, A. N. & Muschel, R. J. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget 7, 28697\u201328710 (2016).","journal-title":"Oncotarget"},{"key":"65048_CR67","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ccell.2024.04.011","volume":"42","author":"MJ van Elsas","year":"2024","unstructured":"van Elsas, M. J. et al. Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy. Cancer Cell 42, 1032\u20131050.e10 (2024).","journal-title":"Cancer Cell"},{"key":"65048_CR68","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3389\/fimmu.2018.00736","volume":"9","author":"D Aga\u00e7","year":"2018","unstructured":"Aga\u00e7, D., Gill, M. A. & Farrar, J. D. Adrenergic signaling at the interface of allergic asthma and viral infections. Front. Immunol. 9, 736 (2018).","journal-title":"Front. Immunol."},{"key":"65048_CR69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.193.3.339","volume":"193","author":"MJ Walter","year":"2001","unstructured":"Walter, M. J., Kajiwara, N., Karanja, P., Castro, M. & Holtzman, M. J. Interleukin 12 P40 Production by Barrier Epithelial Cells during Airway Inflammation. J. Exp. Med. 193, 339 (2001).","journal-title":"J. Exp. Med."},{"key":"65048_CR70","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.crimmu.2021.11.001","volume":"2","author":"S Chhatar","year":"2021","unstructured":"Chhatar, S. & Lal, G. Role of adrenergic receptor signaling in neuroimmune communication. Cur Res Immunol. 2, 202\u2013217 (2021).","journal-title":"Cur Res Immunol."},{"key":"65048_CR71","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1172\/JCI119674","volume":"100","author":"P Panina-Bordignon","year":"1997","unstructured":"Panina-Bordignon, P. et al. \u03b22-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100, 1513\u20131519 (1997).","journal-title":"J. Clin. Invest."},{"key":"65048_CR72","doi-asserted-by":"publisher","first-page":"22699","DOI":"10.1073\/pnas.1821218116","volume":"116","author":"SC Wei","year":"2019","unstructured":"Wei, S. C. et al. Combination anti\u2013CTLA-4 plus anti\u2013PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies. Proc. Natl Acad. Sci. 116, 22699\u201322709 (2019).","journal-title":"Proc. Natl Acad. Sci."},{"key":"65048_CR73","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma, P. et al. Immune checkpoint therapy\u2014current perspectives and future directions. Cell 186, 1652\u20131669 (2023).","journal-title":"Cell"},{"key":"65048_CR74","doi-asserted-by":"publisher","first-page":"e1405205","DOI":"10.1080\/2162402X.2017.1405205","volume":"7","author":"KM Kokolus","year":"2017","unstructured":"Kokolus, K. M. et al. Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. Oncoimmunology 7, e1405205 (2017).","journal-title":"Oncoimmunology"},{"key":"65048_CR75","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2019.10.029","volume":"179","author":"S Jiao","year":"2019","unstructured":"Jiao, S. et al. Differences in tumor microenvironment dictate T helper lineage polarization and response to immune checkpoint therapy. Cell 179, 1177\u20131190.e13 (2019).","journal-title":"Cell"},{"key":"65048_CR76","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.chom.2009.10.007","volume":"6","author":"TM Hohl","year":"2009","unstructured":"Hohl, T. M. et al. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 6, 470\u2013481 (2009).","journal-title":"Cell Host Microbe"},{"key":"65048_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 1\u20137 (2017).","journal-title":"Sci. Rep."},{"key":"65048_CR78","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/cyto.a.24350","volume":"101","author":"TM Ashhurst","year":"2022","unstructured":"Ashhurst, T. M. et al. Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre. Cytom. A 101, 237\u2013253 (2022).","journal-title":"Cytom. A"},{"key":"65048_CR79","doi-asserted-by":"publisher","first-page":"768113","DOI":"10.3389\/fimmu.2021.768113","volume":"12","author":"H den Braanker","year":"2021","unstructured":"den Braanker, H., Bongenaar, M. & Lubberts, E. How to prepare spectral flow cytometry datasets for high dimensional data analysis: a practical workflow. Front. Immunol. 12, 768113 (2021).","journal-title":"Front. Immunol."},{"key":"65048_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-40790-0","volume":"14","author":"S Puccio","year":"2023","unstructured":"Puccio, S. et al. CRUSTY: a versatile web platform for the rapid analysis and visualization of high-dimensional flow cytometry data. Nat. Commun. 14, 1\u20137 (2023).","journal-title":"Nat. Commun."},{"key":"65048_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-020-00783-w","volume":"12","author":"F Petitprez","year":"2020","unstructured":"Petitprez, F. et al. The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression. Genome Med. 12, 1\u201315 (2020).","journal-title":"Genome Med."},{"key":"65048_CR82","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"key":"65048_CR83","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1462431","volume":"7","author":"DP Enot","year":"2018","unstructured":"Enot, D. P., Vacchelli, E., Jacquelot, N., Zitvogel, L. & Kroemer, G. TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves. Oncoimmunology 7, e1462431 (2018).","journal-title":"Oncoimmunology"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65048-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65048-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65048-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:02:22Z","timestamp":1763402542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65048-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65048"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65048-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5653750\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10063"}}